- Home
- TNXP vs RMBI Comparison
TNXP vs RMBI Comparison
Compare TNXP & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- RMBI
- Stock Information
- Founded
- TNXP 2007
- RMBI 1887
- Country
- TNXP United States
- RMBI United States
- Employees
- TNXP N/A
- RMBI N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- RMBI Major Banks
- Sector
- TNXP Health Care
- RMBI Finance
- Exchange
- TNXP Nasdaq
- RMBI Nasdaq
- Market Cap
- TNXP 116.9M
- RMBI 125.7M
- IPO Year
- TNXP N/A
- RMBI 2019
- Fundamental
- Price
- TNXP $15.71
- RMBI $12.95
- Analyst Decision
- TNXP Strong Buy
- RMBI
- Analyst Count
- TNXP 2
- RMBI 0
- Target Price
- TNXP $585.00
- RMBI N/A
- AVG Volume (30 Days)
- TNXP 1.5M
- RMBI 29.0K
- Earning Date
- TNXP 05-12-2025
- RMBI 04-28-2025
- Dividend Yield
- TNXP N/A
- RMBI 4.67%
- EPS Growth
- TNXP N/A
- RMBI 1.10
- EPS
- TNXP N/A
- RMBI 0.92
- Revenue
- TNXP $10,094,000.00
- RMBI $42,915,048.00
- Revenue This Year
- TNXP $12.17
- RMBI N/A
- Revenue Next Year
- TNXP $789.15
- RMBI N/A
- P/E Ratio
- TNXP N/A
- RMBI $14.08
- Revenue Growth
- TNXP 29.94
- RMBI 2.81
- 52 Week Low
- TNXP $6.76
- RMBI $10.15
- 52 Week High
- TNXP $672.00
- RMBI $15.15
- Technical
- Relative Strength Index (RSI)
- TNXP 44.80
- RMBI 57.83
- Support Level
- TNXP $15.23
- RMBI $11.98
- Resistance Level
- TNXP $22.25
- RMBI $12.80
- Average True Range (ATR)
- TNXP 2.36
- RMBI 0.49
- MACD
- TNXP -0.54
- RMBI 0.04
- Stochastic Oscillator
- TNXP 16.54
- RMBI 83.76
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.